Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-000260
Filing Date
2021-01-08
Accepted
2021-01-08 15:30:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 28795
2 filename2.txt TEXT-EXTRACT 2982
  Complete submission text file 0000000000-21-000260.txt   43341
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filed for) CIK: 0001816736 (see all company filings)

EIN.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations